Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
Elber Yuksel Aydin, 1, 2 Andrea Schneider, 1, 3 Dragana Protic, 1, 4 Jun Yi Wang, 1, 5 Veronica Martínez-Cerdeño, 1, 6 Flora Tassone, 1, 7 Hiu-Tung Tang, 7 Susan Perlman, 8 Randi J Hagerman 1, 3 1Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, Universit...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/55d204acf3554e82b1473115f34cf433 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:55d204acf3554e82b1473115f34cf433 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:55d204acf3554e82b1473115f34cf4332021-12-02T09:48:58ZRapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease1178-1998https://doaj.org/article/55d204acf3554e82b1473115f34cf4332020-02-01T00:00:00Zhttps://www.dovepress.com/rapidly-progressing-neurocognitive-disorder-in-a-male-with-fxtas-and-a-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Elber Yuksel Aydin, 1, 2 Andrea Schneider, 1, 3 Dragana Protic, 1, 4 Jun Yi Wang, 1, 5 Veronica Martínez-Cerdeño, 1, 6 Flora Tassone, 1, 7 Hiu-Tung Tang, 7 Susan Perlman, 8 Randi J Hagerman 1, 3 1Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, Sacramento, CA, USA; 2Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; 3Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA; 4Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Belgrade, Serbia; 5Center for Mind and Brain, University of California Davis School of Medicine, Sacramento, CA, USA; 6Department of Pathology and Laboratory Medicine, Institute for Pediatric Regenerative Medicine, University of California Davis School of Medicine and Shriners Hospital, Sacramento, CA, USA; 7Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, CA, USA; 8Department of Neurology, University of California Los Angeles School of Medicine, Los Angeles, CA, USACorrespondence: Randi J HagermanMIND Institute UCDMC, 2825 50th Street, Sacramento, CA 95817, USAEmail rjhagerman@ucdavis.eduAbstract: Fragile X–associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder that usually begins in the early 60s and affects carriers of premutation expansion (55– 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. Additional disorders can co-occur with FXTAS including Alzheimer’s disease (AD). Here we discuss a case report of a male with 67 CGG repeats in FMR1 who had mild late-onset FXTAS symptoms followed by neurocognitive disorder symptoms consistent with AD. The patient has developed tremor and ataxia that are the two characteristic symptoms of FXTAS. In addition, he shows rapid cognitive decline, brain atrophy most substantial in the medial temporal lobe, and decreased metabolism in the brain regions that are the characteristic findings of AD. The purpose of this study is to describe a patient profile with both diseases and review the details of an overlap between these two diseases.Keywords: FXTAS, Alzheimer’s disease, cognitive decline, neurocognitive disorder, premutation, neurogeneticsAydin EYSchneider AProtic DWang JYMartínez-Cerdeño VTassone FTang HTPerlman SHagerman RJDove Medical Pressarticlefxtasalzheimer’s diseasecognitive declineneurocognitive disorderpremutationneurogeneticsGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 285-292 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
fxtas alzheimer’s disease cognitive decline neurocognitive disorder premutation neurogenetics Geriatrics RC952-954.6 |
| spellingShingle |
fxtas alzheimer’s disease cognitive decline neurocognitive disorder premutation neurogenetics Geriatrics RC952-954.6 Aydin EY Schneider A Protic D Wang JY Martínez-Cerdeño V Tassone F Tang HT Perlman S Hagerman RJ Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| description |
Elber Yuksel Aydin, 1, 2 Andrea Schneider, 1, 3 Dragana Protic, 1, 4 Jun Yi Wang, 1, 5 Veronica Martínez-Cerdeño, 1, 6 Flora Tassone, 1, 7 Hiu-Tung Tang, 7 Susan Perlman, 8 Randi J Hagerman 1, 3 1Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, Sacramento, CA, USA; 2Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; 3Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA; 4Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Belgrade, Serbia; 5Center for Mind and Brain, University of California Davis School of Medicine, Sacramento, CA, USA; 6Department of Pathology and Laboratory Medicine, Institute for Pediatric Regenerative Medicine, University of California Davis School of Medicine and Shriners Hospital, Sacramento, CA, USA; 7Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, CA, USA; 8Department of Neurology, University of California Los Angeles School of Medicine, Los Angeles, CA, USACorrespondence: Randi J HagermanMIND Institute UCDMC, 2825 50th Street, Sacramento, CA 95817, USAEmail rjhagerman@ucdavis.eduAbstract: Fragile X–associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder that usually begins in the early 60s and affects carriers of premutation expansion (55– 200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. Additional disorders can co-occur with FXTAS including Alzheimer’s disease (AD). Here we discuss a case report of a male with 67 CGG repeats in FMR1 who had mild late-onset FXTAS symptoms followed by neurocognitive disorder symptoms consistent with AD. The patient has developed tremor and ataxia that are the two characteristic symptoms of FXTAS. In addition, he shows rapid cognitive decline, brain atrophy most substantial in the medial temporal lobe, and decreased metabolism in the brain regions that are the characteristic findings of AD. The purpose of this study is to describe a patient profile with both diseases and review the details of an overlap between these two diseases.Keywords: FXTAS, Alzheimer’s disease, cognitive decline, neurocognitive disorder, premutation, neurogenetics |
| format |
article |
| author |
Aydin EY Schneider A Protic D Wang JY Martínez-Cerdeño V Tassone F Tang HT Perlman S Hagerman RJ |
| author_facet |
Aydin EY Schneider A Protic D Wang JY Martínez-Cerdeño V Tassone F Tang HT Perlman S Hagerman RJ |
| author_sort |
Aydin EY |
| title |
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| title_short |
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| title_full |
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| title_fullStr |
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| title_full_unstemmed |
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease |
| title_sort |
rapidly progressing neurocognitive disorder in a male with fxtas and alzheimer’s disease |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/55d204acf3554e82b1473115f34cf433 |
| work_keys_str_mv |
AT aydiney rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT schneidera rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT proticd rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT wangjy rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT martinezcerdenov rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT tassonef rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT tanght rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT perlmans rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease AT hagermanrj rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimerrsquosdisease |
| _version_ |
1718398004437712896 |